 |
Apidra wins approval for use by childrenEuropean Commission has approved Apidra, a rapid-acting insulin analog for the control of hyperglycemia in adolescents and children with diabetes, Sanofi-aventis has announced. The approval of Apidra (insulin glulisine [rDNA origin] inject More… |
Thursday 25 April 2024
